Can Mufarreh Ahmedi, a Herbal Unani Medicine, Help Reduce Acid Peptic Disease Symptoms? A Clinical Study

Clinical Evaluation of Mufarreh Ahmedi in the management of Humuzathe medi(Acid Peptic Disease) non randomised single arm clinical trial- a pilot study - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/083794

Enrollment

Registered

2025-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K20-K31- Diseases of esophagus, stomach and duodenum Health Condition 2: K297- Gastritis, unspecified

Interventions

Intervention1: Mufarreh Ahmedi: 10 grams twice a day after food with water orally FOR 21 DAYS MINIMUM TO 45 DAYS MAXIMUM, if the symptoms totally subside, it will be stopped in 21 days, or else it wil

Eligibility

Inclusion criteria

Inclusion criteria: Patients with symptoms of epigastric burning, heart burn, belching, abdominal pain, abdominal bloating

Exclusion criteria

Exclusion criteria: patients below 20 years, above 60 years, Diseases like Carcinoma of stomach, Acute pancreatitis, Cholelithiasis, patients with history of cardiac pathology, immunodeficiency disorders, patients with history of haematemesis, malena and anaemia, smoking an alcoholic, pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
relief clinical features mentioned in gastritisTimepoint: 15 days, 30 days and 45 days after starting therapy	—

Secondary

Measure	Time frame
expecting no immediate adverse effectsTimepoint: 15 days, 30 days and 45 days after starting therapy	—

Countries

India

Contacts

Public ContactDR V HABIBULLAH

Government Unani Medical College

urnetdoctor@gmail.com9841196001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026